Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arixtra(Fondaparinux) vs. Lovenox (Enoxaparin) in Prevention of DVT in Acute Medically Ill, Non-surgical Patients

NCT00521885 is registered in ClinicalTrials.gov with Lehigh Valley Hospital as lead sponsor.

NCT NCT00521885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00521885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arixtra(Fondaparinux) vs. Lovenox (Enoxaparin) in Prevention of DVT in Acute Medically Ill, Non-surgical Patients
Lead sponsor
Lehigh Valley Hospital
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2007
Completion date
September 30, 2009
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thrombosis